ReP USP - Resultado da busca

Artigo de periodico
Early diagnosis and treatment of acute heart failure in prehospital and emergency settings. Part 1 of the International Expert Opinion Series on acute heart failure management (2025)
Miro, Oscar; Chioncel, Ovidiu; Mebazaa, Alex; Sato, Naoki; Butler, Javed; Davison, Beth; Biegus, Jan; Pagnesi, Matteo; Ambrosy, Andrew P.; Bocchi, Edimar Alcides
Source: European Journal of Emergency Medicine. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, FÁRMACOS, CONSENSO, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRO, Oscar et al. Early diagnosis and treatment of acute heart failure in prehospital and emergency settings. Part 1 of the International Expert Opinion Series on acute heart failure management. European Journal of Emergency Medicine, v. 32, n. 6, p. 392-404, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/90797. Acesso em: 22 abr. 2026.
APA
Miro, O., Chioncel, O., Mebazaa, A., Sato, N., Butler, J., Davison, B., et al. (2025). Early diagnosis and treatment of acute heart failure in prehospital and emergency settings. Part 1 of the International Expert Opinion Series on acute heart failure management. European Journal of Emergency Medicine, 32( 6), 392-404. doi:10.1097/MEJ.0000000000001270
NLM
Miro O, Chioncel O, Mebazaa A, Sato N, Butler J, Davison B, Biegus J, Pagnesi M, Ambrosy AP, Bocchi EA. Early diagnosis and treatment of acute heart failure in prehospital and emergency settings. Part 1 of the International Expert Opinion Series on acute heart failure management [Internet]. European Journal of Emergency Medicine. 2025 ; 32( 6): 392-404.[citado 2026 abr. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90797
Vancouver
Miro O, Chioncel O, Mebazaa A, Sato N, Butler J, Davison B, Biegus J, Pagnesi M, Ambrosy AP, Bocchi EA. Early diagnosis and treatment of acute heart failure in prehospital and emergency settings. Part 1 of the International Expert Opinion Series on acute heart failure management [Internet]. European Journal of Emergency Medicine. 2025 ; 32( 6): 392-404.[citado 2026 abr. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90797
Artigo de periodico
Special topics: heart failure-related cardiogenic shock, valvular heart disease and end-stage renal disease. Part 4 of the International Expert Opinion Series on Acute Heart Failure Management (2025)
Pagnesi, Matteo; Riccardi, Mauro; Cotter, Gad; Lima, Ivna G. C. V.; Davison, Beth; Ambrosy, Andrew P.; Biegus, Jan; Bocchi, Edimar Alcides ; Butler, Javed; Dzudie, Anastase
Source: Heart Failure Reviews. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, INSUFICIÊNCIA RENAL AGUDA, MORTALIDADE, CHOQUE CARDIOGÊNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAGNESI, Matteo et al. Special topics: heart failure-related cardiogenic shock, valvular heart disease and end-stage renal disease. Part 4 of the International Expert Opinion Series on Acute Heart Failure Management. Heart Failure Reviews, v. 30, n. 6, p. 1559-1589, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/90795. Acesso em: 22 abr. 2026.
APA
Pagnesi, M., Riccardi, M., Cotter, G., Lima, I. G. C. V., Davison, B., Ambrosy, A. P., et al. (2025). Special topics: heart failure-related cardiogenic shock, valvular heart disease and end-stage renal disease. Part 4 of the International Expert Opinion Series on Acute Heart Failure Management. Heart Failure Reviews, 30( 6), 1559-1589. doi:10.1007/s10741-025-10568-1
NLM
Pagnesi M, Riccardi M, Cotter G, Lima IGCV, Davison B, Ambrosy AP, Biegus J, Bocchi EA, Butler J, Dzudie A. Special topics: heart failure-related cardiogenic shock, valvular heart disease and end-stage renal disease. Part 4 of the International Expert Opinion Series on Acute Heart Failure Management [Internet]. Heart Failure Reviews. 2025 ; 30( 6): 1559-1589.[citado 2026 abr. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90795
Vancouver
Pagnesi M, Riccardi M, Cotter G, Lima IGCV, Davison B, Ambrosy AP, Biegus J, Bocchi EA, Butler J, Dzudie A. Special topics: heart failure-related cardiogenic shock, valvular heart disease and end-stage renal disease. Part 4 of the International Expert Opinion Series on Acute Heart Failure Management [Internet]. Heart Failure Reviews. 2025 ; 30( 6): 1559-1589.[citado 2026 abr. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90795
Artigo de periodico
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction (2022)
Butler, Javed ; Filippatos, Gerasimos ; Siddiqi, Tariq Jamal; Ferreira, Joao Pedro ; Brueckmann, Martina ; Bocchi, Edimar Alcides ; Bohm, Michael ; Chopra, Vijay K. ; Giannetti, Nadia ; Iwata, Tomoko
Source: Circulation. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, HOMENS, MULHERES, PACIENTES INTERNADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUTLER, Javed et al. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation, v. 146, n. 14, p. 1046-1055, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50467. Acesso em: 22 abr. 2026.
APA
Butler, J., Filippatos, G., Siddiqi, T. J., Ferreira, J. P., Brueckmann, M., Bocchi, E. A., et al. (2022). Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction. Circulation, 146( 14), 1046-1055. doi:10.1161/CIRCULATIONAHA.122.059755
NLM
Butler J, Filippatos G, Siddiqi TJ, Ferreira JP, Brueckmann M, Bocchi EA, Bohm M, Chopra VK, Giannetti N, Iwata T. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction [Internet]. Circulation. 2022 ; 146( 14): 1046-1055.[citado 2026 abr. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50467
Vancouver
Butler J, Filippatos G, Siddiqi TJ, Ferreira JP, Brueckmann M, Bocchi EA, Bohm M, Chopra VK, Giannetti N, Iwata T. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction [Internet]. Circulation. 2022 ; 146( 14): 1046-1055.[citado 2026 abr. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50467
Artigo de periodico
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022)
Butler, Javed ; Anker, Stefan D ; Lund, Lars H. ; Coats, Andrew J. S.; Filippatos, Gerasimos ; Siddiqi, Tariq Jamal; FRIEDE, Tim ; Fabien, Vincent ; Kosiborod, Mikhail; Metra, Marco
Source: European heart journal. Unidade: FM
Subjects: PLACEBOS, POTÁSSIO, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUTLER, Javed et al. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, v. 43, n. 41, p. 4362-4373, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50465. Acesso em: 22 abr. 2026.
APA
Butler, J., Anker, S. D., Lund, L. H., Coats, A. J. S., Filippatos, G., Siddiqi, T. J., et al. (2022). Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, 43( 41), 4362-4373. doi:10.1093/eurheartj/ehac401
NLM
Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2026 abr. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465
Vancouver
Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2026 abr. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465
Artigo de periodico
The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study (2021)
Jankowska, Ewa A; Kirwan, Bridget-Anne; Kosiborod, Mikhail; Butler, Javed; Anker, Stefan D; Mcdonagh, Theresa; Dorobantu, Maria; Drozdz, Jaroslaw; Filippatos, Gerasimos; Nicolau, Jose Carlos
Source: European heart journal. Unidade: FM
Subjects: FERRO, INSUFICIÊNCIA CARDÍACA, FERRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANKOWSKA, Ewa A et al. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, v. 42, n. 31, p. 3011-+, 2021Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehab234. Acesso em: 22 abr. 2026.
APA
Jankowska, E. A., Kirwan, B. -A., Kosiborod, M., Butler, J., Anker, S. D., Mcdonagh, T., et al. (2021). The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, 42( 31), 3011-+. doi:10.1093/eurheartj/ehab234
NLM
Jankowska EA, Kirwan B-A, Kosiborod M, Butler J, Anker SD, Mcdonagh T, Dorobantu M, Drozdz J, Filippatos G, Nicolau JC. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [Internet]. European heart journal. 2021 ; 42( 31): 3011-+.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1093/eurheartj/ehab234
Vancouver
Jankowska EA, Kirwan B-A, Kosiborod M, Butler J, Anker SD, Mcdonagh T, Dorobantu M, Drozdz J, Filippatos G, Nicolau JC. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [Internet]. European heart journal. 2021 ; 42( 31): 3011-+.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1093/eurheartj/ehab234
Artigo de periodico
Cardiovascular and renal outcomes with empagliflozin in heart failure (2020)
Packer, Milton; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Pocock, Stuart J; Carson, Peter; Januzzi, James; Verma, Subodh; Tsutsui, Hiroyuki; Bocchi, Edimar Alcides
Source: New england journal of medicine. Unidade: FM
Subjects: ENVELHECIMENTO, DOENÇAS CARDIOVASCULARES, MORTALIDADE, PREVENÇÃO E CONTROLE, INSUFICIÊNCIA CARDÍACA, FISIOPATOLOGIA, INSUFICIÊNCIA RENAL CRÔNICA, HOSPITALIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PACKER, Milton et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. New england journal of medicine, v. 383, n. 15, p. 1413-1424, 2020Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa2022190. Acesso em: 22 abr. 2026.
APA
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., et al. (2020). Cardiovascular and renal outcomes with empagliflozin in heart failure. New england journal of medicine, 383( 15), 1413-1424. doi:10.1056/NEJMoa2022190
NLM
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Bocchi EA. Cardiovascular and renal outcomes with empagliflozin in heart failure [Internet]. New england journal of medicine. 2020 ; 383( 15): 1413-1424.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1056/NEJMoa2022190
Vancouver
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Bocchi EA. Cardiovascular and renal outcomes with empagliflozin in heart failure [Internet]. New england journal of medicine. 2020 ; 383( 15): 1413-1424.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1056/NEJMoa2022190
Artigo de periodico
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020)
Anker, Stefan D; Butler, Javed; Khan, Muhammad Shahzeb; Abraham, William T; Bauersachs, Johann; Bocchi, Edimar Alcides ; Bozkurt, Biykem; Braunwald, Eugene; Chopra, Vijay K; Cleland, John G
Source: European heart journal. Unidade: FM
Subjects: CARDIOLOGIA, INSUFICIÊNCIA CARDÍACA, CORONAVIRUS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANKER, Stefan D et al. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European heart journal, v. 41, n. 22, p. 2109-2117, 2020Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehaa461. Acesso em: 22 abr. 2026.
APA
Anker, S. D., Butler, J., Khan, M. S., Abraham, W. T., Bauersachs, J., Bocchi, E. A., et al. (2020). Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European heart journal, 41( 22), 2109-2117. doi:10.1093/eurheartj/ehaa461
NLM
Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi EA, Bozkurt B, Braunwald E, Chopra VK, Cleland JG. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) [Internet]. European heart journal. 2020 ; 41( 22): 2109-2117.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1093/eurheartj/ehaa461
Vancouver
Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi EA, Bozkurt B, Braunwald E, Chopra VK, Cleland JG. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) [Internet]. European heart journal. 2020 ; 41( 22): 2109-2117.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1093/eurheartj/ehaa461
Artigo de periodico
Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial (2019)
Packer, Milton; Butler, Javed; Filippatos, Gerasimos S; Jamal, Waheed; Salsali, Afshin; Schnee, Janet; Kimura, Karen; Zeller, Cordula; George, Jyothis; Bocchi, Edimar Alcides
Source: European journal of heart failure. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, PROTEÍNAS DE TRANSPORTE, MORBIDADE, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, GLICOSÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PACKER, Milton et al. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. European journal of heart failure, v. 21, n. 10, p. 1270-1278, 2019Tradução . . Disponível em: https://doi.org/10.1002/ejhf.1536. Acesso em: 22 abr. 2026.
APA
Packer, M., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J., et al. (2019). Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. European journal of heart failure, 21( 10), 1270-1278. doi:10.1002/ejhf.1536
NLM
Packer M, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Bocchi EA. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial [Internet]. European journal of heart failure. 2019 ; 21( 10): 1270-1278.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1002/ejhf.1536
Vancouver
Packer M, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Bocchi EA. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial [Internet]. European journal of heart failure. 2019 ; 21( 10): 1270-1278.[citado 2026 abr. 22 ] Available from: https://doi.org/10.1002/ejhf.1536

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration